Damian Garde covers the global drug industry and contributes to STAT’s industry-leading events. He has written stories on the polarizing approval of a new Alzheimer’s disease treatment, the race to develop a Covid-19 vaccine, and sexual harassment at an influential biotech investment fund.
Previously Damian worked at Bloomberg News and FierceBiotech. He lives in New York. You can reach him by email, and confidential tips are welcome on Signal at damiangarde.67.
Journalistic ethics: Damian adheres to the standards outlined in the STAT ethics policy. STAT is committed to truth, accuracy, impartiality, and transparency in our reporting.
